Atlas Trials

Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population

Clinical trial NCT00318058 · COMPLETED

Trial details

NCT number
NCT00318058
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza
Start date
2005-10-03
Primary completion
2005-11-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.